- Home
- GNFT vs FT Comparison
GNFT vs FT Comparison
Compare GNFT & FT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNFT
- FT
- Stock Information
- Founded
- GNFT 1999
- FT 1988
- Country
- GNFT France
- FT United States
- Employees
- GNFT N/A
- FT N/A
- Industry
- GNFT Biotechnology: Biological Products (No Diagnostic Substances)
- FT Trusts Except Educational Religious and Charitable
- Sector
- GNFT Health Care
- FT Finance
- Exchange
- GNFT Nasdaq
- FT Nasdaq
- Market Cap
- GNFT 211.1M
- FT 171.4M
- IPO Year
- GNFT 2019
- FT N/A
- Fundamental
- Price
- GNFT $4.34
- FT $7.52
- Analyst Decision
- GNFT Strong Buy
- FT
- Analyst Count
- GNFT 1
- FT 0
- Target Price
- GNFT $13.00
- FT N/A
- AVG Volume (30 Days)
- GNFT 4.6K
- FT 63.0K
- Earning Date
- GNFT 09-19-2024
- FT 01-01-0001
- Dividend Yield
- GNFT N/A
- FT 7.85%
- EPS Growth
- GNFT N/A
- FT N/A
- EPS
- GNFT N/A
- FT N/A
- Revenue
- GNFT $38,115,397.00
- FT N/A
- Revenue This Year
- GNFT $171.45
- FT N/A
- Revenue Next Year
- GNFT N/A
- FT N/A
- P/E Ratio
- GNFT N/A
- FT N/A
- Revenue Growth
- GNFT 31.38
- FT N/A
- 52 Week Low
- GNFT $2.89
- FT $5.97
- 52 Week High
- GNFT $6.05
- FT $7.23
- Technical
- Relative Strength Index (RSI)
- GNFT 54.93
- FT 79.01
- Support Level
- GNFT $3.90
- FT $7.31
- Resistance Level
- GNFT $4.45
- FT $7.33
- Average True Range (ATR)
- GNFT 0.25
- FT 0.06
- MACD
- GNFT 0.01
- FT 0.01
- Stochastic Oscillator
- GNFT 80.51
- FT 84.87
About GNFT GENFIT S.A.
Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of innovative medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.